{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:22Z","timestamp":1791928942572,"version":"4.3.4"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,7,6]]},"DOI":"10.1167\/iovs.67.8.17","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:42:58Z","timestamp":1783341778000},"page":"17","source":"Crossref","is-referenced-by-count":0,"title":["AAV8-Mediated Retinal PD-L1 Gene Transfer Attenuates Experimental Autoimmune Uveitis by Restoring Local Immune Tolerance"],"prefix":"10.1167","volume":"67","author":[{"given":"Quanxi","family":"Lai","sequence":"first","affiliation":[{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China"},{"name":"State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Jin","sequence":"additional","affiliation":[{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China"},{"name":"State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Ding","sequence":"additional","affiliation":[{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piao","family":"Jiang","sequence":"additional","affiliation":[{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyue","family":"Fang","sequence":"additional","affiliation":[{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China"},{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyi","family":"Li","sequence":"additional","affiliation":[{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China"},{"name":"State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China"},{"name":"Zhejiang Key Laboratory of Ophthalmic Drug Discovery and Medical Device Research, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shi","sequence":"additional","affiliation":[{"name":"National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China"},{"name":"State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China"},{"name":"Zhejiang Key Laboratory of Ophthalmic Drug Discovery and Medical Device Research, Eye Hospital, Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"744396","DOI":"10.3389\/fimmu.2021.744396","article-title":"Epidemiology of ocular manifestations in autoimmune disease","volume":"12","author":"Glover","year":"2021","journal-title":"Front Immunol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"e70021","DOI":"10.1002\/mco2.70021","article-title":"Ocular immune-related diseases: molecular mechanisms and therapy","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajo.2024.04.026","article-title":"Intraocular immune response in human uveitis: time to look beyond animal models","volume":"266","author":"Basu","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2174\/0115665240311578241014050805","article-title":"Advances in the study of the pathogenesis of Vogt-Koyanagi-Harada syndrome","volume":"25","author":"Wang","year":"2025","journal-title":"Curr Mol Med"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ajpath.2020.09.004","article-title":"Characterization of clinical and immune responses in an experimental chronic autoimmune uveitis model","volume":"191","author":"Fan","year":"2021","journal-title":"Am J Pathol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","article-title":"The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases","volume":"19","author":"DeMaio","year":"2022","journal-title":"J Neuroinflammation"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41577-024-01064-y","article-title":"Redefining our vision: an updated guide to the ocular immune system","volume":"24","author":"Wu","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12967-025-07520-0","article-title":"Single-cell transcriptomic profiling reveals aberrant CD4? naive T cell differentiation driving immune activation in Beh\u00e7et's uveitis","volume":"24","author":"Zhang","year":"2026","journal-title":"J Transl Med"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cytogfr.2022.07.003","article-title":"Revisiting PD-1\/PD-L pathway in T and B cell response: beyond immunosuppression","volume":"67","author":"Lu","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"bib10","first-page":"107","article-title":"Research progress on the role of PD-1\/PD-L1 pathway in autoimmune eye diseases","volume":"42","author":"Chenling","year":"2022","journal-title":"J Shanghai Jiao Tong Univ (Med Sci)"},{"key":"bib11","article-title":"Retinal pigment epithelium-derived PD-L1 reprograms microglial cells and protects against retinal degeneration in mouse models of experimental AMD and genetic retinitis pigmentosa","author":"Su","year":"2025","journal-title":"bioRxiv"},{"key":"bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-025-03766-4","article-title":"Nanomedicine targeting the PD-1\/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance","volume":"23","author":"Xiang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12886-024-03575-7","article-title":"Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of uveitis","volume":"24","author":"Brown","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/08820538.2024.2433636","article-title":"Ocular immune-related adverse events associated with PD-1 inhibitors: from molecular mechanisms to clinical management","volume":"40","author":"Gong","year":"2025","journal-title":"Semin Ophthalmol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/09273948.2020.1781902","article-title":"Immune checkpoint inhibitor-associated uveitis: review of treatments and outcomes","volume":"29","author":"Dow","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"20033","DOI":"10.1038\/s41598-024-68401-y","article-title":"Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis","volume":"14","author":"Quinn","year":"2024","journal-title":"Sci Rep"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1111\/cpr.70007","article-title":"PD-L1 promotes immunological tolerance and enhances visual protection of hESC-RPE grafts in retinal degeneration","volume":"58","author":"Li","year":"2025","journal-title":"Cell Prolif"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"2400747","DOI":"10.1002\/advs.202400747","article-title":"Immune checkpoint PD-L1 modulates retinal microglial activation to alleviate vascular leakage in choroidal neovascularization via ERK","volume":"12","author":"Zou","year":"2025","journal-title":"Adv Sci"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.64.13.39","article-title":"Local myeloid-derived suppressor cells impair progression of experimental autoimmune uveitis by alleviating oxidative stress and inflammation","volume":"64","author":"Lee","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"109303","DOI":"10.1016\/j.clim.2023.109303","article-title":"Interferon-a2a induces CD4+ T cell apoptosis and suppresses Th1\/Th17 responses via upregulating IRF1-mediated PDL1 expression in dendritic cells from Behcet's uveitis","volume":"250","author":"Zhu","year":"2023","journal-title":"Clin Immunol"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.23838\/pfm.2025.00009","article-title":"Efficacy and adverse events of immune checkpoint inhibitors: evidence from non-small cell lung cancer and gastric cancer in Korea and Japan","volume":"9","author":"Valencia","year":"2025","journal-title":"Precis Future Med"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3390\/biomedicines12112547","article-title":"Emerging ocular side effects of immune checkpoint inhibitors: a comprehensive review","volume":"12","author":"Wu","year":"2024","journal-title":"Biomedicines"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1186\/s12967-024-05661-2","article-title":"Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside","volume":"22","author":"Xu","year":"2024","journal-title":"J Transl Med"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1038\/s41467-024-48221-4","article-title":"An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species","volume":"15","author":"Luo","year":"2024","journal-title":"Nat Commun"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"201677","DOI":"10.1016\/j.omta.2026.201677","article-title":"Interrogating the dependency of AAV capsids on AAVR for retinal transduction","volume":"34","author":"Hinsch","year":"2026","journal-title":"Mol Ther Adv"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"e157038","DOI":"10.1172\/jci.insight.157038","article-title":"CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis","volume":"7","author":"Zhang","year":"2022","journal-title":"JCI Insight"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"101957","DOI":"10.1016\/j.gendis.2025.101957","article-title":"Type III interferons attenuate Th1\/Th17 cell pathogenicity and regulate retinal pigment epithelium cells via NLRP1\/NLRP3 signaling axis in autoimmune uveitis","volume":"13","author":"Wang","year":"2025","journal-title":"Genes Dis"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1006\/jaut.1993.1048","article-title":"Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat.","volume":"6","author":"de Smet","year":"1993","journal-title":"J Autoimmun."},{"key":"bib30","doi-asserted-by":"publisher","first-page":"103122","DOI":"10.1016\/j.autrev.2022.103122","article-title":"From ocular immune privilege to primary autoimmune diseases of the eye","volume":"21","author":"Nieto-Aristiz\u00e1bal","year":"2022","journal-title":"Autoimmun Rev"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11882-023-01088-9","article-title":"Autoimmune inflammatory eye disease: demystifying clinical presentations for the Internist","volume":"23","author":"Woodward","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1002\/cncr.30258","article-title":"Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies","volume":"122","author":"Algazi","year":"2016","journal-title":"Cancer"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/ccr3.911","article-title":"Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma","volume":"5","author":"Matsuo","year":"2017","journal-title":"Clin Case Rep"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09273948.2019.1577978","article-title":"Uveitis in patients treated with CTLA-4 and PD-1 checkpoint blockade inhibition","volume":"28","author":"Sun","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/jleuko\/qiac016","article-title":"Ocular immune privilege and retinal pigment epithelial cells","volume":"113","author":"Du","year":"2023","journal-title":"J Leukoc Biol"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors\u2013implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"bib37","doi-asserted-by":"crossref","first-page":"101354","DOI":"10.1016\/j.preteyeres.2025.101354","article-title":"Gene therapy-associated uveitis (GTAU): understanding and mitigating the adverse immune response in retinal gene therapy","author":"Purdy","year":"2025","journal-title":"Prog Retin Eye Res"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/hum.2023.227","article-title":"Role of FoxP3+ regulatory T cells in modulating immune responses to adeno-associated virus gene therapy","volume":"35","author":"Mu\u00f1oz-Melero","year":"2024","journal-title":"Hum Gene Ther"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.8.17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:14Z","timestamp":1791927134000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.8.17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.8.17","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,6]]}}}